These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14529073)

  • 1. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
    Sidwell RU; Swift S; Yan CL; Porter W; Thompson EM; Clark JA; Bunker CB
    Int J Clin Pract; 2003 Sep; 57(7):643-5. PubMed ID: 14529073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic epidermal necrolysis and intravenous immunoglobulin: a review.
    Trent J; Halem M; French LE; Kerdel F
    Semin Cutan Med Surg; 2006 Jun; 25(2):91-3. PubMed ID: 16908399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
    Simeone F; Rubio ER
    J La State Med Soc; 2003; 155(5):266-9. PubMed ID: 14748489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis.
    Al-Mutairi N; Arun J; Osama NE; Amr Z; Mazen AS; Ibtesam el-A; Nazeha el-B
    Int J Dermatol; 2004 Nov; 43(11):847-51. PubMed ID: 15533072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
    Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
    Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Khalili B; Bahna SL
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
    Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
    Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
    Stella M; Clemente A; Bollero D; Risso D; Dalmasso P
    Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
    French LE; Trent JT; Kerdel FA
    Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IVIG for the treatment of toxic epidermal necrolysis.
    Mittmann N; Chan BC; Knowles S; Shear NH
    Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of toxic epidermal necrolysis (TEN) with low dose intravenous immunoglobulin in child.
    Habib A; Pasha W; Raza N
    J Coll Physicians Surg Pak; 2010 Mar; 20(3):205-7. PubMed ID: 20392387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic epidermal necrolysis (Lyell's disease).
    Lissia M; Mulas P; Bulla A; Rubino C
    Burns; 2010 Mar; 36(2):152-63. PubMed ID: 19766401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.
    Paquet P; Jacob E; Damas P; Pirson J; Piérard G
    Arch Dermatol Res; 2005 Dec; 297(6):266-73. PubMed ID: 16249890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxic epidermal necrolysis. Therapy in ICU with intravenous immunoglobulins in a case].
    Andresen M; Boghero Y; Molgó M; Dougnao A; Díaz O
    Rev Med Chil; 2000 Dec; 128(12):1343-8. PubMed ID: 11227243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.
    Yip LW; Thong BY; Tan AW; Khin LW; Chng HH; Heng WJ
    Eye (Lond); 2005 Aug; 19(8):846-53. PubMed ID: 15389280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe drug-related skin reaction: toxic epidermal necrolysis caused by carbamazepine].
    Fischer M; Hamm H; Wirbelauer J
    Klin Padiatr; 2004; 216(5):288-93. PubMed ID: 15455296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis after paroxetine treatment.
    Ahmed R; Eagleton C
    N Z Med J; 2008 May; 121(1274):86-9. PubMed ID: 18535650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdomyolysis as a potential complication of carbamazepine-induced toxic epidermal necrolysis.
    Huang LY; Lin CM; Chiou CC; Lin WS; Cheng SM
    Clin Biochem; 2012 Nov; 45(16-17):1531-2. PubMed ID: 22728955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.